3 stocks Neil Woodford should buy more of

I believe that these three Neil Woodford stocks look undervalued.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here are three under-the-radar Neil Woodford holdings that I believe are worth buying today. 

Used cars 

BCA Marketplace (LSE: BCA) owns and operates vehicle buying services across Europe, such as the well-known UK brand, We Buy Any Car.

Over the past five years, this company has grown from an upstart, into a multi-billion pound business. For the fiscal year ending 31 March 2018, City analysts have pencilled in a pre-tax profit of £108m, up from a loss of £0.3m for 2014. As profits have flowed, BCA’s shares have doubled in value since 2014. 

And even though some analysts are becoming concerned about the current state of the UK car market, I believe BCA’s growth will continue.

As new car sales are falling, used car transactions are holding up well. For example, 1.6m new cars joined British roads during the first eight months of the year, down 2.4% year-on-year. However, during the first half of 2017, used car sales grew 1.3% year-on-year to 4.2m. 

As the volume of used car transactions continues to grow, and BCA bolts-on more growth, City analysts expect the company’s earnings per share to expand by 15% this fiscal year, and 12% for 2019. The shares currently trade at a forward P/E of 19.8 and support a dividend yield of 3.6%. 

Growth champion 

Speciality pharmaceutical company BTG (LSE: BTG) is projected to grow earnings per share by 29% for the fiscal year ending 31 March 2018 as pre-tax profit surges 370%. 

At the beginning of July, management confirmed that the company is on track to hit this target as it is set to achieve “double-digit product sales growth” for the year ending March 31 2018, driven by growth in its interventional medicines business. As well as growth in the established business, BTG is progressing well with the development of new products, receiving positive outcomes from two clinical trials for its blood clot treatment Ekos, varicose vein treatment Varithena and PneumRx coils products.

Shares in BTG are not cheap, trading at a forward P/E of 22.2 but considering the company’s growth rate, and treatment pipeline, I believe this is a premium worth paying. Indeed, at the time of writing, the shares are trading at a PEG ratio of 0.8, implying that they offer growth at a reasonable price. 

Property income 

New River REIT (LSE: NRR) owns and operates a portfolio of shopping centres, retail warehouses, public houses and mixed-use development opportunities.  

Neil Woodford clearly likes New River because of the company’s dividend potential. As a REIT, the company has to pay 90% of its rental income out to investors. This year the firm is projected to earn 21.5p and pay 20.7p to investors for a dividend yield of 6%. I believe investors could be in line for a higher distribution however as last year the company issued a 3p per share special dividend at the end of the year, increasing the full-year payout by 24%. 

Over the past five years, shares in New River have produced a return for investors of 87% excluding dividends. Including dividends, the shares have delivered a total return of 111%.

The one downside is that due to New River’s generous dividend policy, the shares trade at a 17% premium to the net asset value of 292p as reported at the end of 2016. 

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has recommended BTG. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

The best time to buy stocks? It might be right now

Short-term issues that delay long-term trends create opportunities to buy stocks. And that could be happening right now with a…

Read more »

Queen Street, one of Cardiff's main shopping streets, busy with Saturday shoppers.
Investing Articles

Here’s why Next stock rose 5% and topped the FTSE 100 today

Next was the leading FTSE 100 stock today, rising 5%. Our writer takes a look at why and asks if…

Read more »

Renewable energies concept collage
Investing Articles

Up 458% in a year, could the Ceres Power share price go even higher?

Christopher Ruane reviews some highs and lows of the Ceres Power share price over the years and wonders whether the…

Read more »

Rolls-Royce's Pearl 10X engine series
Investing Articles

Are the glory days over for Rolls-Royce shares?

Rolls-Royce shares have soared in recent years. Lately, though, they have taken a tumble. Could there be worse still to…

Read more »

Group of friends meet up in a pub
Investing Articles

Are ‘66% off’ Diageo shares a once-in-a-decade opportunity?

Diageo shares have taken another hit in the early weeks of 2026. Are we looking at a massive bargain or…

Read more »

Investing Articles

Meet the UK stock under £1.50 smashing Rolls-Royce shares over the past year

While Rolls-Royce shares get all the attention, this under-the-radar trust has quietly made investors a fortune. But is it still…

Read more »

UK financial background: share prices and stock graph overlaid on an image of the Union Jack
Investing Articles

Down 19%, the red lights are flashing for Barclays shares!

Barclays shares have fallen almost a fifth in value as the Middle East war has intensified. Royston Wild argues that…

Read more »

Aviva logo on glass meeting room door
Investing Articles

After falling another 5%, are Aviva shares too cheap to ignore?

£10,000 invested in Aviva shares five years ago would have grown 50% by now. But what might the future hold,…

Read more »